Physician profile
Stefanie Danielle Sunnes
NPI 1700175486
$1,289.01
in general payments reported to CMS, 2019-2025
7 companies · $22.34 in 2025
The $22.34 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.19 · 2020: $227 · 2021: $347 · 2022: $223 · 2023: $191 · 2024: $181 · 2025: $22.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.63 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $863.72 | 2019-2025 | Invisalign |
| Nobel Biocare USA | $192.50 | 2019-2023 | Nobelactive |
| Zimmer Biomet Holdings, INC. | $108.72 | 2020 | |
| Dental Health Products, INC. | $44.96 | 2019 | |
| Philips North America LLC | $41.34 | 2022-2023 | |
| Dentsply Sirona INC | $24.64 | 2022-2023 | Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive |
| Elevate Oral Care | $13.13 | 2024 | Fluorimax Mint, Advantage Arrest, Just Right 5000 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefanie Sunnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.